PVIVAX

Knowledge sharing for relapsing malaria

PVIVAX Knowledge sharing for relapsing malaria

Search

  • P. vivax malaria
    • Malaria and P. vivax malaria
    • Symptoms & severity
    • Illness and mortality
    • Populations at risk
      • Pregnant women and children
      • Migratory populations
    • Role in malaria elimination
    • Lifecycle
    • Relapses
    • Vectors
  • Diagnosis & treatment
    • Diagnostic methods
      • Microscopy
      • Rapid diagnostic tests
      • Molecular methods & serology
    • Diagnosing severe vivax malaria
    • Treatment
      • Radical cure
      • Blood stage treatment
      • Liver stage treatment
    • G6PD Deficiency
      • G6PD Global Prevalence
      • G6PD diagnostics
      • Types of G6PD clinical diagnostic tests
  • Regions & countries
    • Africa
    • Eastern Mediterranean
    • South East Asia
    • The Americas
    • Western Pacific
  • In the field
    • Projects
      • The Partnership for Vivax Elimination (PAVE)
    • Stories and Videos
  • Tools
    • Study database
  • Resources
    • The Tafenoquine Rollout Study (TRuST) Factsheet, September 2023
  • News & events
    • Past events
  • About us
HomeResourcesThe Tafenoquine Rollout Study (TRuST) Factsheet, September 2023

The Tafenoquine Rollout Study (TRuST) Factsheet, September 2023

18 Sep 2023
The Partnership for Vivax Elimination (PAVE)

Tafenoquine Roll-oUt Study (TRuST)

pdf
Tafenoquine Roll-oUt Study (TRuST).pdf
432.41 KB

O estudo TRuST, 2023 (Portuguese version)

pdf
O estudo TRuST, 2023.pdf
433.44 KB

Details

Resource type
Fact sheet
Published by
The Partnership for Vivax Elimination (PAVE)

Get in touch

Contact us.

Submit information

Subscribe

Join the mailing list

Follow us

  • Twitter
  • LinkedIn
  • Facebook
  • Disclaimer
  • Privacy policy
A Remora website by Manta Ray Media